Leishmaniasis groups some neglected diseases caused by intracellular protozoa
Leishmania. Its main clinical forms are the tegumentary (LT) and Visceral (LV). Currently, the …

Millions of people worldwide are affected by leishmaniasis, caused by the Leishmania
parasite. Effective treatment is challenging due to the biological complexity of the parasite …

Leishmaniasis is an endemic disease caused by protozoa of the genus Leishmania, which
affects around two million people worldwide. One major drawback in the treatment of …

In this study, the chemical composition and in vitro antileishmanial activity of essential oils
(EOs) from Protium heptaphyllum fresh young (PY-EO) and adult (PA-EO) leaves against …

Cutaneous leishmaniasis, caused by protozoa of the genus Leishmania, presents diverse
clinical manifestations, and current therapeutic options have limitations, including long …

Currently, the therapeutic arsenal available for the treatment of leishmaniasis is limited.
Thus, the aim of this study was to evaluate the in vitro and in vivo antileishmanial efficacy of …

Cutaneous leishmaniasis is a disease caused by protozoa of the genus Leishmania and,
currently, the treatment of first choice is meglumine antimoniate. However, due to its limited …

In the research for the development of new drugs for the therapy of American tegumentary
leishmaniasis, copper has been studied for its antileishmania activity. This study aims to …

As leishmanioses são doenças prevalentes e negligenciadas que afetam à saúde pública e
estão cada vez mais presentes nos países em desenvolvimento. A ampla distribuição dos …

Neglected Tropical Diseases (NTDs) are prevalent in tropical regions with high social
vulnerability. The Brazilian government has established a research and development …